In-person session | Learn
What is psylocibin and how is it advancing treatment for Major Depressive Disorder?
Josh Seoane will be facilitating a lively discussion on some of the latest work of psylocibin therapy in “Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder” from JAMA Psychiatry.
You won’t want to miss out on this week’s discussion bringing together curious minds around cutting-edge Life Science research.
This month’s article citation:
Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(5):481–489. doi:10.1001/jamapsychiatry.2020.3285
A collaboration with CIC Labs and Venture Café, an in-person monthly discussion series that tackles the most recent research papers in the Life Sciences. Our goal is to bring together various perspectives to leverage our collective expertise to advance discoveries and knowledge in the Life Sciences.
